<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>TABLE 1</label>
 <caption>
  <p>Group identification, dosage, and associated description used in 
   <italic>in vivo</italic> study.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1">Group identity</th>
    <th align="center" rowspan="1" colspan="1">Group name</th>
    <th align="left" rowspan="1" colspan="1">Description</th>
    <th align="left" rowspan="1" colspan="1">Treatment given (dosage)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">G1</td>
    <td align="left" rowspan="1" colspan="1">NC</td>
    <td align="left" rowspan="1" colspan="1">Normal control</td>
    <td align="left" rowspan="1" colspan="1">Normal saline (equivalent volume, p.o.)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">G2</td>
    <td align="left" rowspan="1" colspan="1">DC</td>
    <td align="left" rowspan="1" colspan="1">Disease control: CIPN model established through intraperitoneal injection of paclitaxel (PTX)</td>
    <td align="left" rowspan="1" colspan="1">PTX (2 mg/kg; i.p. qd×6)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">G3</td>
    <td align="left" rowspan="1" colspan="1">GABA</td>
    <td align="left" rowspan="1" colspan="1">Treatment with gabapentin (GABA)</td>
    <td align="left" rowspan="1" colspan="1">PTX (2 mg/kg; i.p. qd×6) + GABA (100 mg/kg; i.p.; qd×2W)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">G4</td>
    <td align="left" rowspan="1" colspan="1">DPK-69</td>
    <td align="left" rowspan="1" colspan="1">Treatment with low dose (1/3 HED) of DPK</td>
    <td align="left" rowspan="1" colspan="1">PTX (2 mg/kg; i.p. qd×6) + DPK (69 mg/kg; p.o.; qd×2W)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">G5</td>
    <td align="left" rowspan="1" colspan="1">DPK-205</td>
    <td align="left" rowspan="1" colspan="1">Treatment with mid-dose (HED) of DPK</td>
    <td align="left" rowspan="1" colspan="1">PTX (2 mg/kg; i.p. qd×6) + DPK (205 mg/kg; p.o.; qd×2W)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">G6</td>
    <td align="left" rowspan="1" colspan="1">DPK-615</td>
    <td align="left" rowspan="1" colspan="1">Treatment with high dose (3× HED) of DPK</td>
    <td align="left" rowspan="1" colspan="1">PTX (2 mg/kg; i.p. qd×6) + DPK (615 mg/kg; p.o.; qd×2W)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>qd, quaque die (L) meaning “once a day”; p.o., per os (L) meaning “by mouth”; i.p., intraperitoneal; ×6, for 6 days; ×2W, for 2 weeks; HED, human equivalent dose.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
